Bone Marrow Assessment in Asymptomatic IgM Monoclonal Gammopathies – Reply to Varettoni <i>et al</i>
Roger G. Owen(Leeds Teaching Hospitals NHS Trust), Shirley D’Sa(University College Hospital), Guy Pratt(University Hospitals Birmingham NHS Foundation Trust), Charalampia Kyriakou(The Royal Free Hospital), Matthew Streetly(King's College - North Carolina), Simon D. Wagner(University of Leicester), Michael P. Lunn(UCL Biomedical Research Centre), Rita Flatley(Royal Marsden NHS Foundation Trust), Feargal McNicholl(University of Ulster), Helen O. McCarthy(Queen's University Belfast), Francis Matthey(Chelsea and Westminster Hospital NHS Foundation Trust), Saad M. B. Rassam(Maidstone and Tunbridge Wells NHS Trust), Rebecca Auer(St Bartholomew's Hospital)
Cited by 1
Related Papers
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2008|605